Literature DB >> 25406165

Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

Briana R De Miranda1, Katriana A Popichak1, Sean L Hammond1, James A Miller1, Stephen Safe2, Ronald B Tjalkens3.   

Abstract

The orphan nuclear receptor NR4A2 (Nurr1) constitutively regulates inflammatory gene expression in glial cells by suppressing DNA binding activity of NF-κB. We recently reported that novel 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methane (C-DIM) compounds that activate NR4A family nuclear receptors in cancer lines also suppress inflammatory gene expression in primary astrocytes and prevent loss of dopaminergic neurons in mice exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and probenecid (MPTPp). In this study, we postulated that the basis for this neuroprotection involves blockade of glial activation and subsequent expression of NF-κB-regulated inflammatory genes. To examine this mechanism, we treated transgenic NF-κB/EGFP reporter mice with MPTPp for 7 days (MPTPp7d) followed by daily oral gavage with either vehicle (corn oil; MPTPp14d) or C-DIMs containing p-methoxyphenyl (C-DIM5), p-hydroxyphenyl (C-DIM8), or p-chlorophenyl (C-DIM12) groups. Each compound conferred significant protection against progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), even when given after 7 days of dosing with MPTPp. C-DIM12 had the greatest neuroprotective activity in MPTPp-treated mice, and was also the most potent compound in suppressing activation of microglia and astrocytes, expression of cytokines and chemokines in quantitative polymerase chain reaction (qPCR) array studies, and in reducing expression of NF-κB/EGFP in the SN. C-DIM12 prevented nuclear export of Nurr1 in dopaminergic neurons and enhanced expression of the Nurr1-regulated proteins tyrosine hydroxylase and the dopamine transporter. These data indicate that NR4A-active C-DIM compounds protect against loss of dopamine neurons in the MPTPp model of PD by preventing glial-mediated neuronal injury and by supporting a dopaminergic phenotype in TH-positive neurons in the SNpc.
© The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson’s disease; microglia; neuroinflammation; orphan nuclear receptors

Mesh:

Substances:

Year:  2014        PMID: 25406165      PMCID: PMC4306720          DOI: 10.1093/toxsci/kfu236

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  49 in total

1.  ATP mediates rapid microglial response to local brain injury in vivo.

Authors:  Dimitrios Davalos; Jaime Grutzendler; Guang Yang; Jiyun V Kim; Yi Zuo; Steffen Jung; Dan R Littman; Michael L Dustin; Wen-Biao Gan
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

Review 2.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Trends Immunol       Date:  2008-07-01       Impact factor: 16.687

Review 3.  Parkinson's disease in the nuclear age of neuroinflammation.

Authors:  Yvonne M Nolan; Aideen M Sullivan; André Toulouse
Journal:  Trends Mol Med       Date:  2013-01-11       Impact factor: 11.951

Review 4.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.

Authors:  Syng-Ook Lee; Maen Abdelrahim; Kyungsil Yoon; Sudhakar Chintharlapalli; Sabitha Papineni; Kyounghyun Kim; Huamin Wang; Stephen Safe
Journal:  Cancer Res       Date:  2010-07-21       Impact factor: 12.701

6.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

7.  Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells.

Authors:  Elisabet Hermanson; Bertrand Joseph; Diogo Castro; Eva Lindqvist; Piia Aarnisalo; Asa Wallén; Gerard Benoit; Bastian Hengerer; Lars Olson; Thomas Perlmann
Journal:  Exp Cell Res       Date:  2003-08-15       Impact factor: 3.905

8.  Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease.

Authors:  Briana R De Miranda; James A Miller; Ryan J Hansen; Paul J Lunghofer; Stephen Safe; Daniel L Gustafson; Dorothy Colagiovanni; Ronald B Tjalkens
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

9.  Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected].

Authors:  Wendy L Thompson; Linda J Van Eldik
Journal:  Brain Res       Date:  2009-07-03       Impact factor: 3.252

10.  The NR4A subgroup: immediate early response genes with pleiotropic physiological roles.

Authors:  Megan A Maxwell; George E O Muscat
Journal:  Nucl Recept Signal       Date:  2006-02-08
View more
  28 in total

1.  Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Impairs AhR and ARNT Signaling and Protects Mouse Neuronal Cells Against Hypoxia.

Authors:  J Rzemieniec; E Litwa; A Wnuk; W Lason; W Krzeptowski; M Kajta
Journal:  Mol Neurobiol       Date:  2015-10-17       Impact factor: 5.590

2.  Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.

Authors:  Mohammad Jodeiri Farshbaf; Mahboobeh Forouzanfar; Kamran Ghaedi; Abbas Kiani-Esfahani; Maryam Peymani; Alireza Shoaraye Nejati; Tayebeh Izadi; Khadijeh Karbalaie; Maryam Noorbakhshnia; Soheila Rahgozar; Hossein Baharvand; Mohammad Hossein Nasr-Esfahani
Journal:  Mol Cell Biochem       Date:  2016-07-19       Impact factor: 3.396

Review 3.  Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2.

Authors:  Xi Li; Ronald B Tjalkens; Rupesh Shrestha; Stephen Safe
Journal:  Chem Biol Drug Des       Date:  2019-07-21       Impact factor: 2.817

Review 4.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

5.  Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

Authors:  Francesca Montarolo; Simona Perga; Serena Martire; Désirée Nicole Navone; Alberto Marchet; Daniela Leotta; Antonio Bertolotto
Journal:  Neurotox Res       Date:  2016-05-09       Impact factor: 3.911

6.  Curcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP(+))-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway.

Authors:  Song Yu; Xu Wang; Xingliang He; Yue Wang; Sujie Gao; Lu Ren; Yan Shi
Journal:  Cell Stress Chaperones       Date:  2016-05-10       Impact factor: 3.667

7.  4-amino-7-chloroquinoline derivatives for treating Parkinson's disease: implications for drug discovery.

Authors:  Chun-Hyung Kim; Pierre Leblanc; Kwang-Soo Kim
Journal:  Expert Opin Drug Discov       Date:  2016-03-07       Impact factor: 6.098

8.  The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.

Authors:  Briana R De Miranda; Katriana A Popichak; Sean L Hammond; Bryce A Jorgensen; Aaron T Phillips; Stephen Safe; Ronald B Tjalkens
Journal:  Mol Pharmacol       Date:  2015-04-09       Impact factor: 4.436

9.  A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.

Authors:  Sean L Hammond; Stephen Safe; Ronald B Tjalkens
Journal:  Neurosci Lett       Date:  2015-09-14       Impact factor: 3.046

10.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.